
3 Medical Devices Maker, Tyres Maker and Hotels and Resorts Company Stocks With a Strong Future Roadmap: Poly Medicure, Apollo Tyres and Indian Hotels Company
Poly Medicure, Apollo Tyres and Indian Hotels Company: ROE of 10.4% to 16.0% and FY22 to FY26 revenue CAGR of 7.9% to 32.7%. Prices as of 11 Nov 2026.
Updated: 12 Nov 2026 • 10:24 am
Posted by:

Quick Answer
The three medical device, tyre and hotel stocks to watch are Poly Medicure, Apollo Tyres and Indian Hotels Company. Their return on equity ranges from 10.4% to 16.0%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.9% to 32.7%. Indian Hotels Company leads on both return on equity at 16.0% and revenue growth at 32.7% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.
Medical device, tyre and hotel stocks let investors follow companies that serve a growing part of the Indian economy. Poly Medicure, Apollo Tyres and Indian Hotels Company cover a medical devices maker, a tyres maker and a hotels and resorts company.
This list covers three medical device, tyre and hotel stocks with complete current figures: Poly Medicure, Apollo Tyres and Indian Hotels Company. Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Medical Device, Tyre and Hotel Stocks?
Medical device, tyre and hotel stocks are listed companies that make needles, syringes, cannulas and other single use medical devices, produce tyres for cars, trucks and farm vehicles, and run luxury and upscale hotels and resorts. Their earnings depend on hospital demand, vehicle and replacement tyre sales and hotel occupancy.
Medical Device, Tyre and Hotel Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Poly Medicure | 1,673.4 | 15,721 | 50.2 | 59.6 | 10.4 | 0.11 |
| Apollo Tyres | 423.85 | 24,413 | 14.3 | 19.2 | 12.4 | 0.22 |
| Indian Hotels Company | 873 | 108,181 | 46.9 | 37.9 | 16.0 | 0.22 |
On valuation, Poly Medicure and Apollo Tyres trade at a P/E below the industry P/E, while Indian Hotels Company trades above it, which reflects the growth the market already expects. Readers comparing medical device, tyre and hotel stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in medical device, tyre and hotel stocks can use the coming numbers to test whether growth is holding.
Why Do Medical Device, Tyre and Hotel Stocks Have a Strong Roadmap in India?
Medical device, tyre and hotel stocks have a strong roadmap in India because growing healthcare access, a rising vehicle base and strong domestic and inbound travel keep widening the market for these companies.
- Medical devices. Hospitals use more single use products.
- Tyres. More vehicles on the road need more tyres.
- Hotels. Travellers choose premium branded stays.
Why Poly Medicure Features Among These Medical Device, Tyre and Hotel Stocks
Among the medical device, tyre and hotel stocks on this list, Poly Medicure makes single-use medical devices such as infusion sets, syringes, catheters, blood management products and dialysis consumables, and it exports to many countries.
Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%. Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%.
In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6.
Roadmap: The company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.
What to watch: Track export growth, new product approvals and plant capacity use.
Why Apollo Tyres Features Among These Medical Device, Tyre and Hotel Stocks
Among the disposable device, rubber wheel and stay shares on this list, Apollo Tyres is an Indian tyre maker with plants in India and Europe that sells passenger car, truck and bus, two-wheeler, farm and off-highway tyres under the Apollo and Vredestein brands.
In the June 2026 quarter, revenue grew 13.3% year on year to Rs 7,456 crore. Revenue rose from Rs 21,071 crore in FY22 to Rs 28,604 crore in FY26, a compound annual growth rate of 7.9%.
Net profit grew from Rs 639 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 21.1%. The company has a return on equity of 12.4%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 24,413 crore. The stock trades at a P/E of 14.3, below the industry P/E of 19.2.
Roadmap: The company is growing its premium and radial offerings and using its European presence to serve global customers. A strong dealer network in India supports replacement sales.
What to watch: Follow raw material costs, replacement demand and the performance of the European business.
Why Indian Hotels Company Features Among These Medical Device, Tyre and Hotel Stocks
Among the three companies on this list, Indian Hotels Company is India's largest hospitality company and part of the Tata Group, operating luxury, upscale and mid-market hotels and resorts under Taj, SeleQtions, Vivanta and Ginger, along with a food, dining and residences business.
The company has a return on equity of 16.0%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 108,181 crore. The stock trades at a P/E of 46.9, above the industry P/E of 37.9.
Revenue rose from Rs 3,211 crore in FY22 to Rs 9,971 crore in FY26, a compound annual growth rate of 32.7%. Net profit grew from Rs 971 crore in FY23 to Rs 2,195 crore in FY26, which works out to a compound annual growth rate of 31.2%. In the June 2026 quarter, revenue grew 15.1% year on year to Rs 2,419 crore, while net profit rose 22.4% to Rs 391 crore.
Roadmap: The company is growing mainly through management contracts and new signings, which add rooms without heavy capital outlay. Its strong brands, a pipeline of new hotels and rising travel and event demand support growth in occupancy and room rates.
What to watch: Track new room signings and openings and the pace of growth in its newer brands.
Poly Medicure vs Apollo Tyres vs Indian Hotels Company on Key Financials
The table below sets the three medical device, tyre and hotel stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Poly Medicure | 961 | 1,995 | 20.0% | 321 | 16.1% |
| Apollo Tyres | 21,071 | 28,604 | 7.9% | 1,372 | 4.8% |
| Indian Hotels Company | 3,211 | 9,971 | 32.7% | 2,195 | 22.0% |
Indian Hotels Company posts the highest return on equity in this group at 16.0%. Apollo Tyres has the largest FY26 revenue at Rs 28,604 crore, and Indian Hotels Company shows the fastest revenue growth with a 32.7% compound annual rate. A useful habit with medical device, tyre and hotel stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Poly Medicure | 445 | 559 | 25.5% |
| Apollo Tyres | 6,580 | 7,456 | 13.3% |
| Indian Hotels Company | 2,102 | 2,419 | 15.1% |
Key Risks to Check Before Investing in Medical Device, Tyre and Hotel Stocks
Every theme carries risks that deserve a check before any decision. For these medical device, tyre and hotel stocks, the main points are: Long-term disposable device, rubber wheel and stay shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Medical device rules. Approvals and quality standards can affect launches.
- Rubber and carbon black costs. Raw material prices can move margins.
- Travel cycles. Bookings and occupancy follow travel demand.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter medical device, tyre and hotel stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Medical Device, Tyre and Hotel Stocks
Medical device, tyre and hotel stocks reward investors who follow demand trends, order books and margins together. Poly Medicure, Apollo Tyres and Indian Hotels Company each have a clear plan to grow. Based on the 11 November 2026 close, Poly Medicure trades at Rs 1,673.4, Apollo Tyres at Rs 423.85 and Indian Hotels Company at Rs 873. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these medical device, tyre and hotel stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track medical device, tyre and hotel stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are medical device, tyre and hotel stocks?
Ans. Medical device, tyre and hotel stocks are listed companies that make needles, syringes, cannulas and other single use medical devices, produce tyres for cars, trucks and farm vehicles, and run luxury and upscale hotels and resorts. Their earnings depend on hospital demand, vehicle and replacement tyre sales and hotel occupancy. This list looks at three of them, Poly Medicure, Apollo Tyres and Indian Hotels Company, using reported FY22 to FY26 financials and the 11 November 2026 closing prices.
Which medical device, tyre and hotel stocks are covered in this list?
Ans. This list covers Poly Medicure, Apollo Tyres and Indian Hotels Company. Based on the 11 November 2026 close, Poly Medicure traded at Rs 1,673.4, Apollo Tyres at Rs 423.85 and Indian Hotels Company at Rs 873. Their return on equity ranges from 10.4% to 16.0%, and their revenue compound annual growth from FY22 to FY26 ranges from 7.9% to 32.7%.
Why do medical device, tyre and hotel stocks have a strong future roadmap in India?
Ans. Medical device, tyre and hotel stocks have a strong roadmap in India because growing healthcare access, a rising vehicle base and strong domestic and inbound travel keep widening the market for these companies. The main drivers are as follows. Medical devices. Hospitals use more single use products. Tyres. More vehicles on the road need more tyres. Hotels. Travellers choose premium branded stays. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Poly Medicure performed financially?
Ans. Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%. Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%. In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6. Looking ahead, the company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.
How has Apollo Tyres performed financially?
Ans. Revenue rose from Rs 21,071 crore in FY22 to Rs 28,604 crore in FY26, a compound annual growth rate of 7.9%. Net profit grew from Rs 639 crore in FY22 to Rs 1,372 crore in FY26, which works out to a compound annual growth rate of 21.1%. In the June 2026 quarter, revenue grew 13.3% year on year to Rs 7,456 crore. The company has a return on equity of 12.4%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 24,413 crore. The stock trades at a P/E of 14.3, below the industry P/E of 19.2. Looking ahead, the company is growing its premium and radial offerings and using its European presence to serve global customers. A strong dealer network in India supports replacement sales.
How has Indian Hotels Company performed financially?
Ans. Revenue rose from Rs 3,211 crore in FY22 to Rs 9,971 crore in FY26, a compound annual growth rate of 32.7%. Net profit grew from Rs 971 crore in FY23 to Rs 2,195 crore in FY26, which works out to a compound annual growth rate of 31.2%. In the June 2026 quarter, revenue grew 15.1% year on year to Rs 2,419 crore, while net profit rose 22.4% to Rs 391 crore. The company has a return on equity of 16.0%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 108,181 crore. The stock trades at a P/E of 46.9, above the industry P/E of 37.9. Looking ahead, the company is growing mainly through management contracts and new signings, which add rooms without heavy capital outlay. Its strong brands, a pipeline of new hotels and rising travel and event demand support growth in occupancy and room rates.
What risks should investors check before buying medical device, tyre and hotel stocks?
Ans. Investors should check a few risks before buying medical device, tyre and hotel stocks. Medical device rules. Approvals and quality standards can affect launches. Rubber and carbon black costs. Raw material prices can move margins. Travel cycles. Bookings and occupancy follow travel demand. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of medical device, tyre and hotel stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
Recent Articles

Mphasis Share Price: 2.8% CAGR in 3 Years as the Bengaluru IT Firm Compares With Persistent Systems and Zensar
12 November 2026

Zensar Technologies Share Price: 4.8% CAGR in 3 Years as the Pune IT Firm Compares With Coforge and Mphasis
12 November 2026

Schaeffler India Share Price: 8.9% CAGR in 3 Years Against Uno Minda and Endurance Technologies
12 November 2026

L&T Share Price: 11.6% CAGR in 3 Years as the Infrastructure Major Compares With ABB India and Cummins India
12 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Mphasis Share Price: 2.8% CAGR in 3 Years as the Bengaluru IT Firm Compares With Persistent Systems and Zensar
Zensar Technologies Share Price: 4.8% CAGR in 3 Years as the Pune IT Firm Compares With Coforge and Mphasis
Schaeffler India Share Price: 8.9% CAGR in 3 Years Against Uno Minda and Endurance Technologies
L&T Share Price: 11.6% CAGR in 3 Years as the Infrastructure Major Compares With ABB India and Cummins India
Ajanta Pharma Share Price: 20.7% CAGR in 3 Years as the Branded Generics Specialist Faces Torrent Pharma and Lupin
Popular this week
AU Small Finance Bank Share Price: 10.8% CAGR in 3 Years as the Jaipur Lender Faces Federal Bank and Axis Bank

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





